FDA Archives - Page 10 of 24 - ��ýҕ�l Health News

What the Health? From ��ýҕ�l Health News

Part I: The State of the Abortion Debate 50 Years After ‘Roe’

Episode 281

Jan. 26, 2023

In Part I of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also in this episode, Rovner interviews Elizabeth Nash of the Guttmacher Institute, about changing reproductive policies in the states.

Listen Now

What the Health? From ��ýҕ�l Health News

GOP House Opens With Abortion Agenda

Episode 279

Jan. 12, 2023

Leaders of the new Republican-led U.S. House kicked off their legislative agenda with two bills supported by anti-abortion groups. While neither is likely to become law, the move demonstrates how abortion will continue to be an issue in Washington. Meanwhile, as open enrollment for the Affordable Care Act nears its end in most states, the number of Americans covered by the plans hits a new high. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Listen Now

A photo shows a pharmacist organizing a medicine drawer.

States Challenge Biden to Lower Drug Prices by Allowing Imports From Canada

Colorado has joined Florida, New Hampshire, and New Mexico in seeking federal permission to import prescription drugs from Canada. President Joe Biden endorsed the approach in his 2020 campaign but has yet to approve any state plan.

By Phil Galewitz

Dec. 14, 2022

Podcast

KHN’s ‘What the Health?’: Congress Races the Clock

Sen. Raphael Warnock’s re-election in Georgia will give Democrats a clear-cut Senate majority for the first time in nearly a decade. Meanwhile, the current Congress has only days left to tackle major unfinished business on the health agenda, including fending off scheduled pay cuts for doctors and other health providers in the Medicare program. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Dec. 8, 2022

A photo shows petri dishes arranged in a row over scans of DNA and RNA.

Patients for Profit: How Private Equity Hijacked Health Care

The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.

Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.

By Rachana Pradhan

Dec. 2, 2022

A photo shows a CVS home STI test on a counter next to its contents.

As STDs Proliferate, Companies Rush to Market At-Home Test Kits. But Are They Reliable?

The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.

By Liz Szabo

Nov. 18, 2022

A photo shows patrons smoking hookah inside of a hookah lounge.

California’s Proposed Flavored Tobacco Ban Gives Hookah a Pass

Californians will decide Nov. 8 whether to approve a statewide ban on the sale of flavored tobacco products, including menthol cigarettes. But the measure, known as Proposition 31, exempts hookah tobacco. Anti-smoking activists criticize the carve-out, calling it the latest example of businesses using identity politics to profit from a deadly product.

By Rachel Scheier

Nov. 3, 2022

A doctor holds a linear ultrasonic diagnostic probe.

Despite Katie Couric’s Advice, Doctors Say Ultrasound Breast Exams May Not Be Needed

When Katie Couric announced she had breast cancer, she urged women to get a mammogram — and, if they have dense breasts, to get supplemental screening by ultrasound. But medical experts point out that ultrasound and other auxiliary screenings haven’t been proven to do more than regular mammography in reducing mortality.

By Michelle Andrews

Oct. 28, 2022

A photo shows a pair of hands holding Sony's new CRE-C10 hearing aids.

Say What? Hearing Aids Available Over-the-Counter for as Low as $199, and Without a Prescription

The cheaper over-the-counter aids are for adults with mild to moderate hearing loss — a market of tens of millions of people, many of whom have until now been priced out because prescription devices can cost thousands of dollars.

By Phil Galewitz

Oct. 17, 2022

A photo shows a sign outside the FDA's headquarters.

Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

By Arthur Allen

Sept. 30, 2022

A photo shows a woman holding a vial of oil and a pipette, suggesting it is Delta-8 oil.

Hemp-Derived Delta-8 Skirts Marijuana Laws and Raises Health Concerns

A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.

By Eric Berger

Sept. 23, 2022

Nutritional formula is poured into a baby bottle. There is a second, empty bottle beside the one being filled. They sit on a wooden countertop.

Formula May Be Right for Infants, but Experts Warn That Toddlers Don’t Need It

Sales of formulas designed for toddlers increased in recent years, but health experts warn parents that, generally, once children reach their 1st birthday, they are fine with cow or plant milk and don’t need the expensive, high-calorie products. And doctors say toddler formula should not be given to infants.

By Christina Szalinski

Sept. 21, 2022

A photo shows pills on a bathroom scale surrounded by a human-shaped cookie cutter, suggesting weight loss.

California and New York Aim to Curb Diet Pill Sales to Minors

California and New York would be the first states to require anyone under 18 to obtain prescriptions to purchase over-the-counter weight loss products, which some research has linked to eating disorders.

By Laurie Udesky

Sept. 14, 2022

A macro photo of covid-19 vaccine bottles. The bottles take up the entire image.

PERSPECTIVE

Did the US Jump the Gun With the New Omicron-Targeted Vaccines?

With fears of a winter surge looming, government agencies have authorized and encouraged vaccination with a newly formulated booster. But the science to support that decision remains inconclusive.

By Céline Gounder and Elisabeth Rosenthal

Sept. 12, 2022

A photo shows Lori McClintock and her husband, Tom McClintock, leaving after casting ballots.

Congressman’s Wife Died After Taking Herbal Remedy Marketed for Diabetes and Weight Loss

Lori McClintock, the wife of U.S. Rep. Tom McClintock of California, died after ingesting white mulberry leaf, according to the Sacramento County coroner. The plant is generally considered safe and is used in herbal remedies that claim to lower blood sugar, boost weight loss, and combat high cholesterol. Her death highlights the potential dangers of dietary supplements.

By Samantha Young

Aug. 24, 2022

Podcast

KHN’s ‘What the Health?’: Wrapping Up Summer’s Health News

President Joe Biden has signed the Inflation Reduction Act and Congress is gone until after Labor Day. But the administration and lawmakers left lots of health policy achievements behind, including new rules to facilitate the sale of over-the-counter hearing aids and a potential reorganization of the Centers for Disease Control and Prevention. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

Aug. 18, 2022

A photo shows a gloved hand holding a box of paxlovid. A blister pack of tablets is seen on the table.

COVID-19

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.

By Michelle Andrews

July 28, 2022

A family photo shows Jacob Boggs holding his daughter Emma and standing next to his daughter Riley and his wife Courtney Boggs.

Parents Become Drug Developers to Save Their Children’s Lives

Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.

By Jared Whitlock

July 21, 2022

A photo shows a blister pack of pills against a blue background.

As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger

Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.

By Arthur Allen

July 15, 2022

Podcast

KHN’s ‘What the Health?’: Life After ‘Roe’ Is … Confusing

A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

July 14, 2022

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

FDA